Postgestational effects of macrophage migration inhibitory factor on embryonic implantation in mice.
To investigate in vivo the effects of macrophage migration inhibitory factor (MIF) on endometrial receptivity and embryonic implantation. A murine experimental model. Animal facilities at Research Center of Saint-François d'Assise Hospital. Ten-week-old B6C3F-1 female mice. Intraperitoneal injections of recombinant mouse MIF or saline (control) the day after successful mating and during the peri-implantation period. Markers of uterine receptivity, including integrins and vascular endothelial growth factor (VEGF) were assessed using real-time polymerase chain reaction (PCR) and immunohistochemistry. Quantitative real-time PCR and immunohistochemical analyses indicated that MIF induced a marked increase in alpha(v) (alphav), beta3 (beta3) integrin subunits and VEGF mRNA, and protein expression in the endometrium. The MIF (10 microg/mL) significantly increased the number of von Willebrand factor-stained microvessels, and a significant correlation between VEGF expression and the number of von Willebrand factor-stained vessels was observed. Moreover, a tendency for an enhanced pregnancy rate (PR) in MIF-treated mice was seen compared with controls. These findings reveal that after gestation, MIF may play an important role in endometrial receptivity and embryonic implantation.